Related references
Note: Only part of the references are listed.Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling
Aimee J. Varewijck et al.
DIABETES (2013)
Regulation of mitochondrial processes by protein S-nitrosylation
Claude A. Piantadosi
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
Young Seok Ju et al.
GENOME RESEARCH (2012)
Redox implications of AMPK-mediated signal transduction beyond energetic clues
Simone Cardaci et al.
JOURNAL OF CELL SCIENCE (2012)
Regulation of protein tyrosine phosphatases by reversible oxidation
Arne Ostman et al.
JOURNAL OF BIOCHEMISTRY (2011)
AMP-activated protein kinase: also regulated by ADP?
D. Grahame Hardie et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
Leonardo Faoro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
The molecular mechanisms that underlie the tumor suppressor function of LKB1
Dahua Fan et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy
Jeroen Poels et al.
BIOESSAYS (2009)
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition
C. L. Mahoney et al.
BRITISH JOURNAL OF CANCER (2009)
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer
Salvador Rodriguez-Nieto et al.
CARCINOGENESIS (2009)
Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio
Brooke M. Emerling et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Identification of the Serine 307 of LKB1 as a Novel Phosphorylation Site Essential for Its Nucleocytoplasmic Transport and Endothelial Cell Angiogenesis
Zhonglin Xie et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Shana N. Wingo et al.
PLOS ONE (2009)
Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas
Cristina M. Contreras et al.
CANCER RESEARCH (2008)
The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity
Shumin Zhang et al.
CANCER RESEARCH (2008)
LKB1 and lung cancer:: More than the usual suspects
Usman Shah et al.
CANCER RESEARCH (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome
M. Sanchez-Cespedes
ONCOGENE (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Prevalence and specificity of LKB1 genetic alterations in lung cancers
S. Matsumoto et al.
ONCOGENE (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
A module of negative feedback regulators defines growth factor signaling
Ido Amit et al.
NATURE GENETICS (2007)
Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential
Zhi-Gang Zhuang et al.
MOLECULAR CANCER RESEARCH (2006)
IGF-I/insulin hybrid receptors in human endothelial cells
MD Nitert et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
Analysis of the LKB1-STRAD-MO25 complex
J Boudeau et al.
JOURNAL OF CELL SCIENCE (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37
P Nony et al.
ONCOGENE (2003)
MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm
J Boudeau et al.
EMBO JOURNAL (2003)
Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction
AJ Finn et al.
NATURE NEUROSCIENCE (2003)
Altered regulation of SHP-2 and PTP 1B tyrosine phosphatases in cystic kidneys from bcl-2-/- mice
CM Sorenson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Protein tyrosine phosphatases: Dephosphorylating the epidermal growth factor receptor
T Tiganis
IUBMB LIFE (2002)
Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice
A Ylikorkala et al.
SCIENCE (2001)
Functional inactivation, of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
AM Fernández et al.
GENES & DEVELOPMENT (2001)
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death
P Karuman et al.
MOLECULAR CELL (2001)
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
H Waterman et al.
FEBS LETTERS (2001)
Share Paper
